New hope for advanced kidney cancer: first human trial of NEO-811 begins
NCT ID NCT07300241
First seen Jan 11, 2026 · Last updated May 11, 2026 · Updated 18 times
Summary
This early-stage study tests a new drug called NEO-811 in people with advanced clear cell kidney cancer that cannot be removed by surgery. About 30 participants who have tried other treatments or cannot take them will receive the drug to see if it is safe and what dose works best. The goal is to control the disease, not to cure it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
NEO-811 Dallas Site
RECRUITINGDallas, Texas, 75039, United States
-
NEO-811 Grand Rapids Site
RECRUITINGGrand Rapids, Michigan, 49503, United States
-
NEO-811 Houston Site
RECRUITINGHouston, Texas, 77054, United States
-
NEO-811 Long Island Site
RECRUITINGLake Success, New York, 11042, United States
-
NEO-811 South Carolina Site
RECRUITINGMyrtle Beach, South Carolina, 29572, United States
-
NEO-811 Virginia Site
RECRUITINGFairfax, Virginia, 22031, United States
-
NEO-811-101 NYC Site
RECRUITINGNew York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.